Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07108803Enrolling By Invitation

European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis

Role: lead

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

NCT06141291Not ApplicableCompleted

Bed Rest Study SBI 2023

Role: collaborator

NCT04596280Unknown

Comparision Among Classifications for Acute Diverticulitis: a Multicenter Study

Role: collaborator

All 4 trials loaded